Clinical pregnancy outcomes with assisted reproduction in patients with 17α-Hydroxylase/17, 20-lyase deficiency: a single center cohort study and integrated analysis with reported cases - Report - MDSpire
Advertisement
Clinical pregnancy outcomes with assisted reproduction in patients with 17α-Hydroxylase/17, 20-lyase deficiency: a single center cohort study and integrated analysis with reported cases
Clinical Report: Pregnancy Outcomes Following Assisted Reproductive Technology in Women with 17α-Hydroxylase/17, 20-Lyase Deficiency
Overview
This study evaluates pregnancy outcomes in women with 17α-hydroxylase/17, 20-lyase deficiency (17OHD) who underwent assisted reproductive technology (ART). It highlights the challenges and complications faced during pregnancies in this population.
Background
17α-hydroxylase/17, 20-lyase deficiency is a rare form of congenital adrenal hyperplasia that affects sexual development and fertility in 46, XX females. With advances in ART, there is a growing interest in understanding the reproductive outcomes and management strategies for these patients.
Data Highlights
Parameter
Value
Median age at pregnancy preparation
29 years (range 21–42)
Hypertension prevalence
25.0% (5/20)
Adrenal insufficiency prevalence
50.0% (10/20)
Pregnancy complications prevalence
46.2% (6/13)
Term vaginal deliveries
25% (5/20)
Key Findings
Three out of six women desiring fertility achieved clinical pregnancy with ART.
A total of 20 pregnancies resulted in 23 live births when combined with reported cases.
Nearly 95% of participants received glucocorticoids before embryo transfer.
Pregnancy complications occurred in 46.2% of cases, including gestational hypertension and preeclampsia.
Only 25% of participants had term vaginal deliveries.
Clinical Implications
The findings indicate that glucocorticoid-assisted progesterone suppression with frozen embryo transfer is a treatment approach used in this population. However, the risks of maternal and perinatal complications require careful monitoring.
Conclusion
Women with 17OHD can achieve pregnancies through ART, but they face significant risks.
